REVELATION BIOSCIENCES, INC. Quarterly Accrued Liabilities, Current in GBP for Q3 2022

Taxonomy & unit
us-gaap: GBP and USD
Description
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Revelation Biosciences, Inc. quarterly Accrued Liabilities, Current history and growth rate for Q3 2022.
  • Revelation Biosciences, Inc. Accrued Liabilities, Current for the quarter ending September 27, 2022 was £1.6M.
Accrued Liabilities, Current, Quarterly (GBP)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 1.6M Sep 27, 2022 10-Q 2023-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.